Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
SEC Accession No. 0001140361-23-047718
Filing Date
2023-10-11
Accepted
2023-10-11 09:27:00
Documents
1
Effectiveness Date
2023-10-11

Document Format Files

Seq Description Document Type Size
1 S-8 POS ny20011256x3-x12_s8pos.htm S-8 POS 28277
  Complete submission text file 0001140361-23-047718.txt   29408
Mailing Address 80 W. LANCASTER AVENUE SUITE 300 DEVON PA 19333
Business Address 80 W. LANCASTER AVENUE SUITE 300 DEVON PA 19333 484-581-7505
Zynerba Pharmaceuticals, Inc. (Filer) CIK: 0001621443 (see all company filings)

EIN.: 260389433 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 POS | Act: 33 | File No.: 333-256028 | Film No.: 231319565
SIC: 2834 Pharmaceutical Preparations